Release Date: 28/12/23 18:42 Summary: Estimated Distribution Announcement Price Sensitive: Yes Download Document 226.32KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%